Nord/LB set a €93.00 ($109.41) price target on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report released on Thursday. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently weighed in on FME. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Monday, October 30th. Deutsche Bank AG set a €84.00 ($98.82) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research report on Tuesday, August 8th. J P Morgan Chase & Co set a €95.40 ($112.24) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Thursday. Berenberg Bank set a €95.60 ($112.47) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Thursday. Finally, Kepler Capital Markets set a €95.00 ($111.76) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Thursday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of Hold and a consensus target price of €89.12 ($104.84).

Fresenius Medical Care AG & Co. (ETR:FME) traded up €0.18 ($0.21) during trading on Thursday, reaching €83.20 ($97.88). The company’s stock had a trading volume of 656,887 shares.

TRADEMARK VIOLATION WARNING: “Fresenius Medical Care AG & Co. (Pref) (FME) Given a €93.00 Price Target at Nord/LB” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/fresenius-medical-care-ag-93-00-price-target-at-nordlb/1678784.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with Analyst Ratings Network's FREE daily email newsletter.